Annual Shareholders Equity
-$4.57 M
-$2.81 M-159.60%
31 December 2023
Summary:
Scinai Immunotherapeutics annual stockholders equity is currently -$4.57 million, with the most recent change of -$2.81 million (-159.60%) on 31 December 2023. During the last 3 years, it has fallen by -$29.80 thousand (-0.66%). SCNI annual shareholders equity is now -128.23% below its all-time high of $16.18 million, reached on 01 December 2017.SCNI Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$10.00 M
+$17.29 M+237.33%
01 September 2024
Summary:
Scinai Immunotherapeutics quarterly stockholders equity is currently $10.00 million, with the most recent change of +$17.29 million (+237.33%) on 01 September 2024. Over the past year, it has increased by +$12.70 million (+471.58%). SCNI quarterly shareholders equity is now -48.57% below its all-time high of $19.45 million, reached on 01 September 2017.SCNI Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SCNI Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -159.6% | +471.6% |
| 3 y3 years | -0.7% | +918.6% |
| 5 y5 years | +75.7% | +153.3% |
SCNI Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -565.3% | at low | at high | +237.3% |
| 5 y | 5 years | -565.3% | +75.7% | at high | +153.3% |
| alltime | all time | -128.2% | +75.7% | -48.6% | +149.3% |
Scinai Immunotherapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $10.00 M(-237.3%) |
| June 2024 | - | -$7.28 M(+42.4%) |
| Mar 2024 | - | -$5.12 M(+12.0%) |
| Dec 2023 | -$4.57 M(+159.6%) | -$4.57 M(+69.7%) |
| Sept 2023 | - | -$2.69 M(-62.1%) |
| June 2023 | - | -$7.11 M(+47.9%) |
| Mar 2023 | - | -$4.81 M(+173.3%) |
| Dec 2022 | -$1.76 M(-279.2%) | -$1.76 M(-167.0%) |
| Sept 2022 | - | $2.63 M(+104.1%) |
| June 2022 | - | $1.29 M(-74.7%) |
| Mar 2022 | - | $5.08 M(+417.6%) |
| Dec 2021 | $982.00 K(-121.6%) | - |
| Dec 2021 | - | $982.00 K(-24.5%) |
| Sept 2021 | - | $1.30 M(-62.8%) |
| June 2021 | - | $3.50 M(-43.9%) |
| Mar 2021 | - | $6.23 M(-237.3%) |
| Dec 2020 | -$4.54 M(-75.8%) | -$4.54 M(+750.2%) |
| Sept 2020 | - | -$533.90 K(-97.0%) |
| June 2020 | - | -$17.96 M(+4.6%) |
| Mar 2020 | - | -$17.17 M(-8.6%) |
| Dec 2019 | -$18.79 M | -$18.79 M(+220.3%) |
| Sept 2019 | - | -$5.87 M(-71.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | -$20.29 M(+140.6%) |
| Mar 2019 | - | -$8.43 M(+1.7%) |
| Dec 2018 | -$8.29 M(-151.2%) | -$8.29 M(-306.3%) |
| Sept 2018 | - | $4.02 M(-12.1%) |
| June 2018 | - | $4.57 M(-61.9%) |
| Mar 2018 | - | $12.00 M(-25.9%) |
| Dec 2017 | $16.18 M(+143.0%) | $16.18 M(-16.8%) |
| Sept 2017 | - | $19.45 M(+223.2%) |
| June 2017 | - | $6.02 M(-25.8%) |
| Mar 2017 | - | $8.11 M(+21.8%) |
| Dec 2016 | $6.66 M(-22.5%) | $6.66 M(-10.1%) |
| Sept 2016 | - | $7.41 M(-4.6%) |
| June 2016 | - | $7.76 M(-8.8%) |
| Mar 2016 | - | $8.51 M(-1.0%) |
| Dec 2015 | $8.59 M(+101.7%) | $8.59 M(-7.5%) |
| Sept 2015 | - | $9.29 M(-2.3%) |
| June 2015 | - | $9.51 M(+156.4%) |
| Mar 2015 | - | $3.71 M(-12.9%) |
| Dec 2014 | $4.26 M(-38.2%) | $4.26 M(-14.2%) |
| Sept 2014 | - | $4.97 M(-27.9%) |
| Dec 2013 | $6.89 M(+15.9%) | $6.89 M |
| Dec 2012 | $5.94 M | - |
FAQ
- What is Scinai Immunotherapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics annual shareholders equity year-on-year change?
- What is Scinai Immunotherapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics quarterly shareholders equity year-on-year change?
What is Scinai Immunotherapeutics annual stockholders equity?
The current annual shareholders equity of SCNI is -$4.57 M
What is the all time high annual shareholders equity for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high annual stockholders equity is $16.18 M
What is Scinai Immunotherapeutics annual shareholders equity year-on-year change?
Over the past year, SCNI annual stockholders equity has changed by -$2.81 M (-159.60%)
What is Scinai Immunotherapeutics quarterly stockholders equity?
The current quarterly shareholders equity of SCNI is $10.00 M
What is the all time high quarterly shareholders equity for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high quarterly stockholders equity is $19.45 M
What is Scinai Immunotherapeutics quarterly shareholders equity year-on-year change?
Over the past year, SCNI quarterly stockholders equity has changed by +$12.70 M (+471.58%)